About 3 700 reports

Italy Pharmaceuticals and Healthcare Report Q3 2016

77 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: SSN pharmaceutical expenditure will decline in 2016 - intensifying the revenue pressures fordrugmakers and pharmacies in Italy, and increasing out-of-pocket costs for the population. The governmentremains committed to remaining under the 3% of GDP budget deficit limit and using any...

985 1 300 818
May 2016

Brazil Pharmaceuticals and Healthcare Report Q3 2016

107 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The current state of political uncertainty will not shake Brazil's leading position as LatinAmerica's largest pharmaceutical and healthcare market. The Brazilian government has been committed toimproving the population's access to healthcare for decades. Having said this, Brazil's private...

985 1 300 818
May 2016

Belarus Pharmaceuticals and Healthcare Report Q3 2016

74 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Belarus poses challenges for multinational drugmakers given government initiatives to reducethe reliance on medicinal imports. The weak ruble has seen prices of foreign medicines rise to unaffordablelevels and has led to state intervention in the form of domestic bias in the medicine...

985 1 300 818
May 2016

Bulgaria Pharmaceuticals and Healthcare Report Q3 2016

79 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The vote of no confidence against Bulgaria's government, despite being unsuccessful, hashighlighted the dissatisfaction of a large proportion of the population with proposed healthcare reforms. Anumber of recent controversies have lowered the public's opinion of its governance, but...

985 1 300 818
May 2016

India Pharmaceuticals and Healthcare Report Q3 2016

118 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The tough operating environment for multinational drugmakers in India will see littleimprovement over the medium term. Designated as a 'Priority Watch List Country' for PhRMA's Special301 submission for 2016, the issues raised largely mirrored those touched upon in the 2015 submission,such...

985 1 300 818
May 2016

Belgium Pharmaceuticals and Healthcare Report Q3 2016

82 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Belgium offers a stable pharmaceutical market with high per capita spending on medicines.However, drugmakers will increasingly find the government less willing to reimburse expensive, innovativemedicines as it struggles to hit its fiscal targets.Headline Expenditure Projections-...

985 1 300 818
May 2016

Austria Pharmaceuticals and Healthcare Report Q3 2016

65 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: GDP growth in Austria is forecast to accelerate to 1.8% in 2016 and 1.9% in 2017, afterexpanding by a moderate 0.6% over the past four years. This modest recovery comes after a long period ofnear-stagnation; Austria's economy grew by just 2.9% between 2008 and 2015. We believe pharmaceuticalspending...

985 1 300 818
May 2016

Botswana Pharmaceuticals and Healthcare Report Q3 2016

55 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The growth of Botswana's pharmaceutical and healthcare markets will remain limited over thecoming years as multinational drugmakers are unlikely to establish a direct manufacturing presence withinthe country. The government's ongoing commitment to alleviating the overwhelming HIV/AIDS...

985 1 300 818
May 2016

Costa Rica Pharmaceuticals and Healthcare Report Q3 2016

41 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The approved loan from the World Bank will help improve the institutional management andorganisation of healthcare delivery in Costa Rica's public healthcare sector, as well as enhance thefinancial sustainability of Costa Rica's universal health insurance scheme. This investment into...

985 1 300 818
May 2016

Cote d`Ivoire Pharmaceuticals and Healthcare Report Q3 2016

55 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Côte d'Ivoire's pharmaceutical and healthcare markets will be given a boost following signs ofimpressive economic growth and the government's ongoing commitment to universal healthcare provision.We expect opportunities for innovative drugmakers to come into fruition over the coming...

985 1 300 818
May 2016

Finland Pharmaceuticals and Healthcare Report Q3 2016

67 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Finland's economy is set to expand at the slowest rate in the eurozone in 2017. Reforms aimedat tackling its uncompetitive labour market will be insufficient to solve its bleak economic situation. Thiswill force the government to make cost savings, with the pharmaceutical and healthcare...

985 1 300 818
May 2016

China Pharmaceuticals and Healthcare Report Q3 2016

161 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Ongoing challenges facing multinational pharmaceutical firms in China will persist into 2016.This includes pricing pressures on off-patented pharmaceuticals, as authorities look to meet the unmetmedical need in the country by expanding access to medicines while curbing rising healthcare...

985 1 300 818
May 2016

Cuba Pharmaceuticals and Healthcare Report Q3 2016

66 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Pharmaceutical investment and commercial opportunities in Cuba will increase at a slow paceover the forecast period. Cuba's biotechnology industry is set to benefit from the lifting of the US tradeembargo, while the world-class Cuban medical research and manufacturing capacity will...

985 1 300 818
May 2016

Anti-Tumor Drugs Companies in China

65 pages • By Asia Market Information & Development Company

This study focuses on China’s Anti-Tumor Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

1 440 1 800 1 152
May 2016

Hypertension Drugs Markets in China

215 pages • By Asia Market Information & Development Company

China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Anti-Obesity Drugs Markets in China

211 pages • By Asia Market Information & Development Company

China's demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Autoimmune Drugs Markets in China

201 pages • By Asia Market Information & Development Company

China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Osteoporosis Drugs Markets in China

205 pages • By Asia Market Information & Development Company

China's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Blood Disease Drugs Markets in China

290 pages • By Asia Market Information & Development Company

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Pediatric Drugs Markets in China

228 pages • By Asia Market Information & Development Company

China's demand for Pediatric Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Lymphoma Treatment Drugs Markets in China

206 pages • By Asia Market Information & Development Company

China's demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Incretion Drugs Markets in China

247 pages • By Asia Market Information & Development Company

China's demand for Incretion Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Mental Illness Drugs Markets in China

251 pages • By Asia Market Information & Development Company

China's demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Central Nervous System Disorder Drugs Markets in China

214 pages • By Asia Market Information & Development Company

China's demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and...

3 200 4 000 2 560
May 2016

Monoclonal Antibody Markets in China

219 pages • By Asia Market Information & Development Company

China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Alzheimer Disease Drugs Markets in China

239 pages • By Asia Market Information & Development Company

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Smoking Cessation Aids Markets in China

193 pages • By Asia Market Information & Development Company

China's demand for Smoking Cessation Aids has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Antibiotics Markets in China

267 pages • By Asia Market Information & Development Company

China's demand for Antibiotics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for...

3 200 4 000 2 560
May 2016

Anti-Tumor Drugs Markets in China

214 pages • By Asia Market Information & Development Company

China's demand for Anti-Tumor Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment...

3 200 4 000 2 560
May 2016

Medicinal & Botanical Pharmaceutical Manufacturers GLOBAL Industry report

150 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s Medicinal & Botanical Pharmaceutical Manufacturers (GLOBAL) analysis is the most definitive and accurate study of the Medicinal & Botanical Pharmaceutical Manufacturers (GLOBAL) sector in 2015.The report is split into two sections and uses both a written and graphical analysis – analysing the 100 largest Medicinal & Botanical...

1 188 1 294 950
May 2016